These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 5000457)

  • 1. A technique in the evaluation of psychotropic medication based on a patient demand schedule: comparison of the efficacy of oxypertine, diazepam and placebo in anxiety.
    Bonn JA; Salkind MR; Rees WL
    Curr Ther Res Clin Exp; 1971 Sep; 13(9):561-7. PubMed ID: 5000457
    [No Abstract]   [Full Text] [Related]  

  • 2. A multicentre clinical trial of oxypertine in anxiety neurosis.
    Mungavin JM
    Postgrad Med J; 1972 Sep; 48(4):Suppl 4:47-54. PubMed ID: 4585548
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparison of diazepam, benzoctamine, and placebo in anxiety states.
    McLeod WR
    Curr Ther Res Clin Exp; 1972 May; 14(5):239-45. PubMed ID: 4623974
    [No Abstract]   [Full Text] [Related]  

  • 4. [Buspirone in the treatment of Generalized Anxiety Disorders].
    Rzewuska M; Sobucka K
    Psychiatr Pol; 1993; 27(5):545-61. PubMed ID: 8255947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of diazepam as an anti-anxiety agent: meta-analysis of double-blind, randomized controlled trials carried out in Japan.
    Inada T; Nozaki S; Inagaki A; Furukawa TA
    Hum Psychopharmacol; 2003 Aug; 18(6):483-7. PubMed ID: 12923829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter double-blind efficacy and safety study comparing alprazolam, diazepam and placebo in clinically anxious patients.
    Cohn JB
    J Clin Psychiatry; 1981 Sep; 42(9):347-51. PubMed ID: 6115853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychomotor effects of diazepam in anxious patients and healthy volunteers.
    Linnoila M; Erwin CW; Brendle A; Simpson D
    J Clin Psychopharmacol; 1983 Apr; 3(2):88-96. PubMed ID: 6404954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study of a new psychopharmaceutical agent, oxypertine, in anxiety states].
    Martínez Salazar F
    Prensa Med Mex; 1973; 38(9):354-61. PubMed ID: 4793354
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparison of the effects of oxazepam and oxypertine in treatment of anxious depressive neuroses].
    Faidherbe J
    Acta Psychiatr Belg; 1976; 76(4):667-77. PubMed ID: 14482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of oxypertine and diazepam in anxiety neurosis seen in hospital out-patients.
    Wadzisz FJ
    Br J Psychiatry; 1972 Nov; 121(564):507-8. PubMed ID: 4563536
    [No Abstract]   [Full Text] [Related]  

  • 11. Relationship of diazepam serum level to antianxiety effects.
    Bowden CL; Fisher JG
    J Clin Psychopharmacol; 1982 Apr; 2(2):110-4. PubMed ID: 6804535
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of anxiety neuroses in general practice using Lorazepam (Tavor)].
    Kaemmerer E
    Munch Med Wochenschr; 1972 Jul; 114(29):1296-8. PubMed ID: 5068376
    [No Abstract]   [Full Text] [Related]  

  • 13. Some recent advances in the management of anxiety.
    Bonn JA
    Postgrad Med J; 1972 Sep; 48(4):Suppl 4:24-6. PubMed ID: 4585546
    [No Abstract]   [Full Text] [Related]  

  • 14. Anxiolytic efficacy and safety of ketazolam compared with diazepam and placebo.
    Kim KK; Sirman A; Trainor FS; Lee BY
    Clin Ther; 1980; 3(1):9-14. PubMed ID: 6105920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-blind comparison of ketazolam, diazepam and placebo in once-a-day vs t.i.d. dosing.
    Anhalt HS; Young R; Roginsky M
    J Clin Psychiatry; 1980 Nov; 41(11):386-92. PubMed ID: 6108319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response to propranolol and diazepam in somatic and psychic anxiety.
    Tyrer PJ; Lader MH
    Br Med J; 1974 Apr; 2(5909):14-6. PubMed ID: 4595181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of prazepam, diazepam, lorazepam and placebo in anxious outpatients in non-psychiatric private practices.
    Zung WW; Daniel JT; King RE; Moore DT
    J Clin Psychiatry; 1981 Jul; 42(7):280-4. PubMed ID: 6113234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Monitoring of diazepam treatment: comparison of the results of gas chromatography and radioreceptor methods].
    Lipska B; Webel L; Sztaniszlav D; Olajos S; Beljajeva R
    Psychiatr Pol; 1991; 25(6):6-10. PubMed ID: 1841397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The side effect profile of buspirone in comparison to active controls and placebo.
    Newton RE; Casten GP; Alms DR; Benes CO; Marunycz JD
    J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):100-2. PubMed ID: 6130065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bromazepam and diazepam in generalized anxiety: a placebo-controlled study of efficacy and withdrawal.
    Fontaine R; Chouinard G; Annable L
    Psychopharmacol Bull; 1984; 20(1):126-7. PubMed ID: 6144130
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.